Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate
Last week, Rockwell Medical Inc (NASDAQ:RMTI) closed the second $7.5 million tranche of the previously announced DaVita Inc (NYSE:DVA) stock purchase agreement of up…
Rockwell Medical Provides Corporate and Clinical Update; Says Closed $7.5M 2nd Tranche Investment From DaVita, Raised $30M Total Capital This Quarter
Receives Additional Feedback from FDA on its IND Application
Rockwell Medical, Inc. (NASDAQ:RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and
Truist Securities Maintains Hold on DaVita, Lowers Price Target to $90
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and lowers the price target from $110 to $90.
67 Biggest Movers From Yesterday
Gainers
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
45 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Medtronic, DaVita To Jointly Form Kidney Health-Focused Company
Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus…
Medtronic and DaVita Form New Kidney Health Technology Company
Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the intent to form a new, independent kidney care-focused medical device company ("NewCo" or "the Company") to enhance the patient treatment experience and improve overall outcomes.
DaVita’s Return on Invested Capital Overview
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters.
